2022

Overview Assessment of Needs Despite 4 decades of efforts and substantial progress in preventing, treating, and managing HIV/AIDS, a safe and effective HIV vaccine continues to be elusive. The development of an HIV vaccine would have a major impact on the spread of this disease and help change the course of the HIV pandemic. (more…)

Overview Assessment of Needs The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HIV disease as part of a nationwide continuing medical education (CME) effort for physicians. Weight gain is common among people with HIV (PWH) who are starting antiretroviral therapy (ART), with regimens containing integrase  strand transfer inhibitors (InSTIs) or (more…)

Overview Assessment of Needs This webinar will highlight important new clinical data presented at the recent 2022 Conference on Retroviruses and Opportunistic Infections from February 12 to 16, with symposia from February 23, 24, and 25. Learning Objectives At the end of this webinar, participants will be able to: List the most recent findings from (more…)

Overview Assessment of Needs This webinar will provide a concise summary of the latest 2021 update to the Centers for Disease Control and Prevention’s preexposure prophylaxis (PrEP) guidelines. The guidelines include new clinical guidance for the prescription of cabotegravir injections as PrEP for sexually active adults, which was approved by the US Food and (more…)

Overview Assessment of Needs This webinar will highlight important new prevention and epidemiologic data in HIV and COVID-19 presented at the recent 2022 Conference on Retroviruses and Opportunistic Infections from February 12 to 16, with symposia from February 23, 24, and 25.    Learning Objectives At the end of this webinar, participants will be able to: (more…)

Overview Assessment of Needs Metabolic changes associated with antiretroviral therapy may increase the risk of cardiovascular complications for people with HIV. This webinar will focus on cardiovascular disease (CVD) risk factors and complications for people with HIV and provide updated recommendations for prevention and treatment. Learning Objectives At the end of this webinar, participants will (more…)

Overview Assessment of Needs People with HIV (PWH) are more likely to have type 2 diabetes than people without HIV. Some HIV medicines may increase the risk of type 2 diabetes in PWH. This webinar will highlight the prevalence of diabetes in PWH and provide an update on management in this population.  Learning Objectives (more…)

Overview Assessment of Needs This webinar will review data related to HIV in transgender populations and describe current and evolving strategies to improve HIV prevention and care, including the effects of gender-affirming care on ART and HIV outcomes. This webinar will provide an update on the World Professional Association for Transgender Health’s (WPATH) latest (more…)

Overview Assessment of Needs Several new antiviral drugs have become available in recent years including therapies for SARS-CoV2 and long-acting agents for HIV prevention and treatment. This webinar will compare and contrast the clinical pharmacology and concentration-effect associations for contemporary antivirals. Modern analytical approaches to define antiviral pharmacokinetic-dynamic relationships will also be discussed. Learning (more…)

Overview Assessment of Needs This case-based panel webinar will discuss the most challenging issues in drug therapy and anticipated barriers to the implementation of long-acting injectable preexposure prophylaxis (PrEP), which was approved by the US Food and Drug Administration in December 2021. This webinar will review key aspects of its clinical pharmacology and the (more…)